211 related articles for article (PubMed ID: 10190897)
21. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
[TBL] [Abstract][Full Text] [Related]
22. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis.
Ishikawa C; Nakachi S; Senba M; Sugai M; Mori N
Carcinogenesis; 2011 Jan; 32(1):110-9. PubMed ID: 20974684
[TBL] [Abstract][Full Text] [Related]
23. Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients.
Li HC; Yashiki S; Sonoda J; Lou H; Ghosh SK; Byrnes JJ; Lema C; Fujiyoshi T; Karasuyama M; Sonoda S
Jpn J Cancer Res; 2000 Jan; 91(1):34-40. PubMed ID: 10744042
[TBL] [Abstract][Full Text] [Related]
24. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.
Mori N; Nunokawa Y; Yamada Y; Ikeda S; Tomonaga M; Yamamoto N
Blood; 1999 Oct; 94(8):2862-70. PubMed ID: 10515890
[TBL] [Abstract][Full Text] [Related]
25. Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo.
Li L; Zhang R; Chen Z; Xue S; Wang X; Ruan C
Mol Biol Rep; 2011 Nov; 38(8):5371-7. PubMed ID: 21390503
[TBL] [Abstract][Full Text] [Related]
26. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
[TBL] [Abstract][Full Text] [Related]
27. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.
Tsushima H; Imaizumi Y; Imanishi D; Fuchigami K; Tomonaga M
Exp Hematol; 1999 Mar; 27(3):433-40. PubMed ID: 10089905
[TBL] [Abstract][Full Text] [Related]
28. Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia.
Shirono K; Hattori T; Hata H; Nishimura H; Takatsuki K
Blood; 1989 May; 73(6):1664-71. PubMed ID: 2713499
[TBL] [Abstract][Full Text] [Related]
29. Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development.
Seeberger H; Starostik P; Schwarz S; Knörr C; Kalla J; Ott G; Müller-Hermelink HK; Greiner A
Lab Invest; 2001 Jul; 81(7):977-86. PubMed ID: 11454987
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.
Kamihira S; Yamada Y; Hirakata Y; Tomonaga M; Sugahara K; Hayashi T; Dateki N; Harasawa H; Nakayama K
Br J Haematol; 2001 Jul; 114(1):63-9. PubMed ID: 11472346
[TBL] [Abstract][Full Text] [Related]
31. A naturally occurring soluble isoform of murine Fas generated by alternative splicing.
Hughes DP; Crispe IN
J Exp Med; 1995 Nov; 182(5):1395-401. PubMed ID: 7595210
[TBL] [Abstract][Full Text] [Related]
32. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
33. Lack of Fas (APO-1/CD95) gene structural alterations or transcript variant ratio changes in breast cancer.
Puiu L; Petrakou E; Apostolidou A; Athanassiadou A; Psiouri L; Papachatzopoulou A; Gorgoulis VG; Kotsinas A; Tzoracoeleftherakis E; Maniatis GM; Voutsinas G
Cancer Lett; 2003 May; 194(1):91-7. PubMed ID: 12706862
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.
Liu C; Cheng J; Mountz JD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):957-63. PubMed ID: 7575433
[TBL] [Abstract][Full Text] [Related]
35. Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type I.
Kagami Y; Tobinai K; Kinoshita T; Nagai H; Hotta T; Seto M; Ueda R; Saito H
Jpn J Cancer Res; 1993 Apr; 84(4):371-8. PubMed ID: 8390425
[TBL] [Abstract][Full Text] [Related]
36. Clinical and oncological significance of aberrant Fas (APO-1/CD95) isoform expression in adult T-cell leukemia.
Kamihira S; Yamada Y; Maeda T
Indian J Clin Biochem; 2000 Aug; 15(Suppl 1):101-9. PubMed ID: 23105273
[TBL] [Abstract][Full Text] [Related]
37. Dominant-negative Fas mutation is reversed by down-expression of c-FLIP.
Bénéteau M; Daburon S; Moreau JF; Taupin JL; Legembre P
Cancer Res; 2007 Jan; 67(1):108-15. PubMed ID: 17210689
[TBL] [Abstract][Full Text] [Related]
38. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309.
Ruckes T; Saul D; Van Snick J; Hermine O; Grassmann R
Blood; 2001 Aug; 98(4):1150-9. PubMed ID: 11493464
[TBL] [Abstract][Full Text] [Related]
39. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.
Shima Y; Nishimoto N; Ogata A; Fujii Y; Yoshizaki K; Kishimoto T
Blood; 1995 Feb; 85(3):757-64. PubMed ID: 7530506
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
